International Assets Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

International Assets Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-77	Closed	-$6K	–	2226
2021 Q1	$6K	Hold	77	–	–	﹤0.01%	1765
2020 Q4	$6K	Buy	+77	New	+$5.72K	﹤0.01%	1611

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

International Assets Investment Management's HZNP Position: Q2 2021 in Review

International Assets Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 77 shares — an estimated $6K sold.

International Assets Investment Management first reported a position in HZNP in Q4 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

International Assets Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
International Assets Investment Management sold 77 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $6K.
International Assets Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 2 quarters.
International Assets Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6K in Q1 2021.
526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.